Sage Journals: Discover world-class research

Open access

Research article

First published 2026

A snapshot of subcutaneous infliximab uses in inflammatory rheumatic diseases: a multicentric Italian study

Stefano Gentileschi, Carla Gaggiano, Francesco Placido [...]

Therapeutic Advances in Musculoskeletal Disease

Open access

Brief report

First published 2025

Switching from intravenous to subcutaneous infliximab is safe and feasible in patients with perianal Crohn’s disease

Pauline Wils, Mathurin Fumery, Maria Nachury [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2025

Comparative efficacy of subcutaneous infliximab switching in remission and non-remission patients with inflammatory bowel disease after intravenous maintenance: 1-year outcome from a multicentre cohort study

June Hwa Bae, Yoo Jin Lee, Jung-Bin Park [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2025

Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis

Marc Ferrante, Laurent Peyrin-Biroulet, Perttu Arkkila [...]

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2023-9

Psoriasis paradox—infliximab-induced psoriasis in a patient with Crohn’s disease: a case report and mini-review

Reem Hamdy A Mohammed, Mahmoud Essam, Ismail Anwar [...]

Journal of International Medical Research

Open access

Research article

First published 2024

Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry

Margalida Calafat, Paola Torres, Joan Tosca-Cuquerella [...]

Therapeutic Advances in Gastroenterology

Retricted access

Research article

First published 2003-9

Infliximab Treatment of Rheumatoid Arthritis and Crohn's Disease

Ibrahim K Nahar, Kam Shojania, Carlo A Marra [...]

Annals of Pharmacotherapy

Free access

Review article

First published 2010-09

Review of the safety and efficacy of ustekinumab

Ellen J. Scherl, Sheila Kumar, Ryan U. Warren

Therapeutic Advances in Gastroenterology

Open access

Research article

First published 2026

Efficacy and safety of the interleukin-10–fragment F8 fusion protein PF-06687234 as add-on therapy to infliximab in patients with active ulcerative colitis: a randomized,phase IIa clinical trial

Stefan Schreiber, Silvio Danese, Séverine Vermeire [...]

Therapeutic Advances in Gastroenterology

Open access

Review article

First published 2011

Patient Considerations in the Management of Rheumatoid Arthritis: Role of Once-A-Month Golimumab Injection

Maria Victoria Garcia, Javier Rosa, Enrique R. Soriano

Clinical Medicine Insights: Therapeutics

Search results